EFFECTIVENESS OF DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS. INTERNATIONAL COOPERATIVE MULTI-CENTER STUDY

被引：0
|
作者：
Jang, J. H. [1 ]
Iastrebner, M. [2 ]
Taborda, G. [3 ]
Arbelbide, J. [4 ]
Sackmann, F. [5 ]
Klein, G. [6 ]
Bernard, H.
Jozami, C. [7 ]
Kim, K. [1 ]
Kim, D. [1 ]
Jung, C. [1 ]
机构：
[1] Samsung Med Ctr, Seoul, South Korea
[2] San Luis Med Ctr, Buenos Aires, DF, Argentina
[3] Policlin Modelo, Cipoletti, Argentina
[4] Hosp Italian, Buenos Aires, DF, Argentina
[5] Fundaleu, Buenos Aires, DF, Argentina
[6] Hosp Rossi Cucaiba, La Plata, Argentina
[7] Hosp Clin Buenos Aires, Buenos Aires, DF, Argentina
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1375
引用
收藏
页码：553 / 554
页数：2
相关论文
共 50 条
  • [1] Effectiveness of Decitabine in Chronic Myelomonocytic Leukemia Patients. International Cooperative Multi-Center Study
    Iastrebner, Marcelo
    Jang, Jun Ho
    Fernandez, Isolda
    Kim, Kihyun
    Garay, Guy
    Kim, Dong Hwan
    Saba, Silvia
    Jung, Chul Won
    Santini, Fernando
    Haydee i Bernard
    Salvatierra, Lino
    Korin, Jorge
    Taborda, Gustavo
    Antonio Giuliani, Ricardo
    Flores, Gabriela
    Flores, Alejandro
    BLOOD, 2009, 114 (22) : 1465 - 1466
  • [2] Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study
    Iastrebner, Marcelo
    Jang, Jun Ho
    Nucifora, Elsa
    Kim, Kihyun
    Sackmann, Federico
    Kim, Dong Hwan
    Orlando, Sergio
    Jung, Chu Won
    Basquiera, Ana
    Bengio, Raquel
    Quiroga, Luis
    Klein, Graciela
    Garcia, Juan
    Arbelbide, Jorge
    Pavlovsky, Astrid
    Virginia Prates, Maria
    BLOOD, 2009, 114 (22) : 1463 - 1463
  • [3] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
    Wijermans, P. W.
    Luebbert, Michael
    Baer, Maria R.
    Slack, James L.
    BLOOD, 2006, 108 (11) : 756A - 757A
  • [4] Decitabine Is Effective and Safe In Patients with Chronic Myelomonocytic Leukemia.
    Jabbour, Elias
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Cornelison, A. Megan
    Kadia, Tapan
    Borthakur, Cautam
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    BLOOD, 2010, 116 (21) : 1644 - 1644
  • [5] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
    Wijermans, P. W.
    Rueter, B.
    Baer, M. R.
    Slack, J. L.
    Saba, H. I.
    Luebbert, M.
    LEUKEMIA RESEARCH, 2008, 32 (04) : 587 - 591
  • [6] Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients
    Santini, V.
    Allione, B.
    Lunghi, M.
    Levis, A.
    Poloni, A.
    Angelucci, E.
    Onida, F.
    Terenzi, A.
    Finelli, C.
    Ferrero, D.
    LEUKEMIA RESEARCH, 2013, 37 : S17 - S17
  • [7] A Phase II Study of Decitabine In Advanced Chronic Myelomonocytic Leukemia (CMML)
    Braun, Thorsten
    Droin, Nathalie
    de Renzis, Benoit
    Dreyfus, Francois
    Laribi, Kamel
    Bouabdallah, Krimo
    Charbonnier, Aude
    Cordonnier, Catherine
    Lafon, Ingrid
    Recher, Christian
    Vey, Norbert
    Bastie, Jean-Noel M.
    Besancon, A.
    Beyne-Rauzy, Odile
    Joly, Bertrand
    Jourdan, Eric
    Legros, Laurence
    Marjanovic, Zora
    Petitdidier, Charlotte
    Royer, Bruno
    Sanhes, Laurence
    Tertian, Gerard
    Vaida, Ioana
    Vallantin, Xavier
    Vekhoff, Anne
    Milic, Marina
    Itzykson, Raphael
    Gardin, Claude
    Ades, Lionel
    Fenaux, Pierre
    Solary, Eric
    BLOOD, 2010, 116 (21) : 780 - 781
  • [8] Immunophenotype of BM cells in chronic myelomonocytic leukemia patients.
    del Cañizo, MC
    Fernandez, ME
    Brufau, A
    Arroyo, JL
    Amigo, ML
    Lopez, A
    Lopez, N
    Orfao, A
    San Miguel, JF
    BLOOD, 1998, 92 (10) : 251B - 251B
  • [9] Decitabine induces high response rates in patients with chronic myelomonocytic leukemia (CMML).
    Jabbour, Elias
    O'Brien, Susan
    Ravandi-Kashani, Farhad
    Cortes, Jorge
    Borthakur, Gautam
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Giles, Francis
    Zanoria, Lourdes
    Davisson, Jan
    Issa, Jean-Pierre
    Kantarjian, Hagop M.
    BLOOD, 2006, 108 (11) : 750A - 750A
  • [10] Results of multi-center study of gleevek therapy of patients with chronic myeloid leukemia in the chronic phase.
    Zaritskii, A. Yu.
    Lomaia, E. G.
    Vinogradova, O. Yu.
    Druzhkova, G. A.
    Kruglov, S. S.
    Abakumov, E. M.
    Sokolova, M. A.
    Nemchenko, I. S.
    Zakharova, E. S.
    Kovalyova, L. G.
    Kolosheinova, T. I.
    Goryacheva, S. R.
    Kolosova, L. Yu.
    Vakhrusheva, M. V.
    Loriya, S. S.
    Chernova, L. A.
    Zakharova, A. V.
    Pospelova, T. I.
    Krylova, I. V.
    Lyamkina, A. S.
    Maciulaitiene, E. R.
    Kuznetsov, S. V.
    Chelysheva, E. Yu.
    Ivanova, V. L.
    Udalyeva, V. Yu.
    Shneider, T. V.
    Ogorodnikova, Yu. S.
    Zhuravlyov, V. S.
    Martynkevich, I. S.
    Domracheva, E. V.
    Afanasyev, B. V.
    Abdulkadyrov, K. M.
    Khoroshko, N. D.
    Turkina, A. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (02): : 13 - 17
12345